En
The "EFMC-WuXi AppTec Award for Excellence in Chemical Biology" will recognise outstanding research in the field of chemical biology as defined by EFMC in The Chemical Biology-Medicinal Chemistry Continuum: EFMC’s Vision1, ChemBioChem 2021, 22, 2823– 2825.
Applicants should have a track record of significant research achievements in chemical biology during the last 10 years in terms of originality and significance of their research contributions.
The Award shall be open to any scientist whose age does not exceed 50 years on January 1st of the year during which the Award is to be presented, and whose accomplishment has not yet been honoured by other EFMC awards. In accordance with the EFMC core values of equal opportunities and inclusiveness; Maternity leaves, as well as leaves taken for health or private reasons are considered upon making the final selection.
Nominations should consist of:
Self-nominations are also accepted.
The Award will be presented at the 2nd EFMC International Symposium on Chemoical Biology (EFMC-ISCB 2025) to be held in Basel, Switerland on January 29-31, 2025.
Deadline for submission: June 30, 2024 | Awardee will be announced in the course of September 2024!
Dr Laurent Meijer (Perha Pharmaceuticals, France)
For his unparalleled achievements in the discovery and development of kinase inhibitors derived from natural sources, both within his academic and biotech endeavors. His groundbreaking work in discovering and developing pharmacological inhibitors has not only advanced fundamental research on protein kinases but also holds promise for addressing various diseases, from cancers to neurological disorders. Dr. Meijer's commitment to innovation and collaboration makes him a deserving candidate for this prestigious award, and his contributions continue to inspire medicinal chemists across Europe and beyond.
Prof. Stuart Conway (University of California, United States)
For his pioneering contribution in medicinal chemistry and epigenetics that has reshaped our understanding of disease treatment. Stuart's groundbreaking research on bromodomain inhibitors has paved the way for new cancer therapies, while his efforts in parasitology offer hope for neglected tropical diseases. Beyond his scientific achievements, Stuart's advocacy for diversity and inclusion in academia sets a powerful example for us all. Today, we honor not only his scientific brilliance but also his commitment to building a more equitable future.
For her ground-breaking contributions to the field of fluorine (19F and 18F) chemistry for applications in medicine and Positron Emission Tomography (PET) Imaging. With over 45 fluorination reactions invented, including groundbreaking methods for 18F-radiolabeling, her contributions have bridged the gap between theory and practice, driving forward crucial technologies for the benefit of society. Prof. Gouverneur's exceptional leadership, coupled with her unwavering commitment to mentorship and training, cements her legacy as a transformative figure in the scientific community. She is truly deserving of recognition as one of the foremost organic chemists globally.
